Peter H St George-Hyslop

This inventor holds 23 USPTO granted patents and 5 published patent applications, plus 2 CIPO patents and 4 EPO patents, primarily in Neurodegenerative Research. Top assignees: University of Toronto, Hsc Research and Development Limited Partnership, The Hospital for Sick Children. Active years: 1998-2011.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Peter H St George-Hyslop. Retrieved from https://idiyas.com/inventor/peter-h-st-george-hyslop

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 23 (Patent Applications = 5)

% Patents Active = 60.9

CIPO Patents = 2 (Patent Applications = 2)

EPO Patents = 4 (Patent Applications = 2)

Average Co-Inventor Count = 2.6

ph-index = 5

Forward Citations = 80(Granted Patents)

Company Filing History:

16 out of 532

University of Toronto

patents

7 out of 36

Hsc Research and Development Limited Partnership

patents

2 out of 167

The Hospital for Sick Children

patents

4. 1 out of 1

Research and Development Limited Partnership

patent

5. 1 out of 1

The Hospital for Sick Children, Hsc Research and Development Limited

patent

6. 4 out of 834,570

Other

patents

where one patent can have more than one assignee

Years Active: 1998-2011

Loading Chart...

Areas of Expertise:

Presenilin Proteins

Alzheimer's Disease

Transgenic Models

Neurodegeneration

Mutant Detection

Neuronal Regeneration

Genetic Sequences

Antibody Specificity

Risk Assessment

Protein Interactions

Schizophrenia Research

PAMP

23 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 8067224 - Presenilin associated membrane protein (PAMP) and uses thereof (2011-11-29),

2. 7846679 - Methods for detecting the presence of mutant mammalian presenilin protein (2010-12-07),

3. 7838247 - Antibody specific for mutant presenilin 2 and method of use thereof (2010-11-23),

4. 7767879 - Transgenic animal model of neurodegenerative disorders (2010-08-03),

5. 7507798 - Antibody specific for mutant presenilin 1 (2009-03-24),

6. 7439326 - Presenilin associated membrane protein (PAMP)and uses thereof (2008-10-21),

7. 7371920 - Transgenic mouse model of neurodegenerative disorders (2008-05-13),

8. 7235383 - Alzheimer's related proteins and methods of use (2007-06-26),

9. 6998467 - Antibody specific for presenilin 1 and method of use thereof (2006-02-14),

10. 6955896 - Alzheimer's related proteins and methods of use (2005-10-18),

11. 6929919 - Proteins related to schizophrenia and uses thereof (2005-08-16),

12. 6812337 - Presenilin associated membrane protein and uses thereof (2004-11-02),

13. 6783982 - Proteins related to neuronal regeneration and uses thereof (2004-08-31),

14. 6531586 - Genetic sequences related to Alzheimer's Disease (2003-03-11),

15. 6485911 - Methods for determining risk of developing alzheimer's disease by detecting mutations in the presenilin 2 (PS-2) gene (2002-11-26),

Title: The Innovative Journey of Peter H. St George-Hyslop

Introduction: Peter H. St George-Hyslop is a renowned inventor based in Toronto, Canada, known for his groundbreaking contributions to the field of neuroscience and genetics.

Latest Patents: Peter H. St George-Hyslop holds several patents in the areas of Alzheimer's disease research, genetic studies, and neurodegenerative disorders. His innovative work has paved the way for advancements in understanding and treating these complex conditions.

Career Highlights: With a distinguished career spanning several decades, Peter H. St George-Hyslop has held key positions in leading research institutions and universities. His research has been instrumental in shaping the field of neurogenetics and has earned him international recognition.

Collaborations: Throughout his career, Peter H. St George-Hyslop has collaborated with top scientists, researchers, and institutions worldwide. His collaborative efforts have resulted in groundbreaking discoveries and have significantly impacted the field of neuroscience.

Conclusion: Peter H. St George-Hyslop's relentless pursuit of innovation and his dedication to advancing the field of neurogenetics have established him as a pioneering figure in the scientific community. His work continues to inspire future generations of inventors and researchers in the quest for understanding and treating complex neurological disorders.

Profile summary based on public USPTO records.